CURRENT OPINION IN LIPIDOLOGY

Scope & Guideline

Bridging the gap between research and clinical practice in lipid health.

Introduction

Welcome to the CURRENT OPINION IN LIPIDOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of CURRENT OPINION IN LIPIDOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0957-9672
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationCURR OPIN LIPIDOL / Curr. Opin. Lipidology
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

CURRENT OPINION IN LIPIDOLOGY serves as a critical platform for the dissemination of contemporary research and insights in lipid metabolism and its clinical implications. The journal is dedicated to publishing high-quality reviews and opinions on the latest advancements in lipidology, focusing on both basic and translational science.
  1. Lipid Metabolism and Disorders:
    The journal extensively covers various aspects of lipid metabolism, including the roles of different lipoproteins, lipid disorders such as familial hypercholesterolemia, and the genetic underpinnings of these conditions.
  2. Cardiovascular Disease (CVD) and Lipids:
    A significant focus is placed on the relationship between lipid levels and cardiovascular risk, with discussions on lipid-lowering therapies, the impact of lipoproteins on atherosclerosis, and emerging insights into cardiovascular health.
  3. Innovative Therapeutics and Interventions:
    The journal highlights novel therapeutic strategies for managing dyslipidemia and related cardiovascular risks, including the exploration of new drug classes and genetic therapies.
  4. Translational Research:
    There is a strong emphasis on translating basic research findings into clinical applications, examining how discoveries in lipid biology can inform patient care and treatment protocols.
  5. Emerging Biomarkers and Risk Assessment:
    The journal discusses the use of new biomarkers and genetic testing in the assessment and management of lipid disorders, enhancing the understanding of individual patient risk profiles.
The journal has seen a rise in interest in several key themes that reflect contemporary challenges and advancements in the field of lipidology. These emerging topics underscore the evolving landscape of research and clinical practice.
  1. Genetic and Genomic Insights into Lipid Disorders:
    There is a growing emphasis on the role of genetics in lipid metabolism and disorders, including familial hypercholesterolemia, highlighting the potential for personalized medicine in lipid management.
  2. Innovative Lipid-Lowering Therapies:
    Emerging therapies, particularly those targeting specific proteins like PCSK9 and ANGPTL3, are gaining traction, showcasing the journal's focus on novel pharmacological interventions.
  3. Interplay Between Lipids and Systemic Conditions:
    Research is increasingly exploring the connections between lipid metabolism and other systemic conditions, such as diabetes, liver disease, and inflammation, reflecting a more integrated understanding of metabolic health.
  4. Impact of Lifestyle Factors on Lipid Profiles:
    There is an uptick in studies examining how lifestyle changes, including diet and exercise, influence lipid profiles and cardiovascular risk, indicating a holistic approach to lipid management.
  5. Technological Advances in Lipid Measurement:
    The journal is also highlighting advancements in methodologies for lipid measurement and analysis, such as lipidomics, which are crucial for understanding lipid function and pathology.

Declining or Waning

In contrast to the emerging themes, certain areas of focus within CURRENT OPINION IN LIPIDOLOGY appear to be declining, indicating a shift in research priorities and interests among authors and readers.
  1. Traditional Dietary Approaches to Lipid Management:
    There is a noticeable decrease in publications centered on traditional dietary interventions for lipid management, as the focus has shifted towards pharmacological and genetic approaches.
  2. Basic Mechanisms of Lipid Biochemistry:
    While foundational research remains important, there appears to be a waning interest in purely biochemical studies of lipids, with a greater emphasis on clinical applications and implications.
  3. Generalized Lipid Profiles without Contextual Risk Factors:
    Publications that discuss lipid profiles in isolation, without considering their contextual relationship with other risk factors for cardiovascular disease, are becoming less common, reflecting a shift towards integrated risk assessment.

Similar Journals

CHEMISTRY AND PHYSICS OF LIPIDS

Advancing lipid science for a healthier tomorrow.
Publisher: ELSEVIER IRELAND LTDISSN: 0009-3084Frequency: 8 issues/year

Chemistry and Physics of Lipids is a prestigious and influential journal dedicated to advancing the understanding of lipid chemistry and biophysics. Published by Elsevier Ireland Ltd, it serves as a vital resource for researchers and professionals in the fields of biochemistry, cell biology, and molecular biology. The journal has a strong standing within the academic community, as reflected in its 2023 Scopus rankings, where it places in the 82nd percentile for organic chemistry and maintains significant positions in various biochemistry subfields. Spanning from 1966 to 2024, it fosters a comprehensive discourse on lipid-related research and innovation. As a renowned publication in the Q2 and Q3 quartiles across several categories, it supports the dissemination of high-quality research aimed at elucidating lipid functions and their implications in health and disease. Researchers and students alike will find this journal invaluable for staying updated with the latest developments and trends in lipid research.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Illuminating the Pathways of Cellular Energy
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0145-479XFrequency: 6 issues/year

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

Journal of Endocrinology and Metabolism

Elevating the understanding of metabolic processes and endocrine functions.
Publisher: ELMER PRESS INCISSN: 1923-2861Frequency: 4 issues/year

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.

Journal of Clinical Lipidology

Exploring the intricate links between lipids and chronic diseases.
Publisher: ELSEVIER SCIENCE INCISSN: 1933-2874Frequency: 6 issues/year

Journal of Clinical Lipidology, published by Elsevier Science Inc, is a leading platform dedicated to advancing the understanding of lipidology and its impact on cardiovascular health. With an ISSN of 1933-2874 and E-ISSN 1876-4789, this esteemed journal boasts a remarkable Q1 ranking in key medical categories, including Cardiology and Cardiovascular Medicine, Internal Medicine, and Nutrition and Dietetics, solidifying its position as a vital resource for the latest research and clinical practices. This journal not only serves as a repository for groundbreaking studies but also provides insights into complex interactions between lipid metabolism and chronic diseases, including diabetes and obesity. Researchers, practitioners, and students will find a wealth of carefully vetted articles that drive innovation and improve patient outcomes in lipid management. Although it does not currently offer open access, the Journal of Clinical Lipidology ensures high visibility through rigorous peer review and a commitment to quality, making it an essential read for anyone invested in the future of lipidology.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pioneering insights into thrombosis and vascular disorders.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

JOURNAL OF MEMBRANE BIOLOGY

Exploring the Intricacies of Membrane Dynamics
Publisher: SPRINGERISSN: 0022-2631Frequency: 6 issues/year

Welcome to the Journal of Membrane Biology, a premier publication dedicated to advancing our understanding of the complex roles membranes play in biological systems. Published by Springer, this journal features research articles, reviews, and communications on a broad range of topics related to membrane biology, including biomolecular interactions, transport mechanisms, and physiological responses. With an ISSN of 0022-2631 and E-ISSN 1432-1424, the journal has been a cornerstone in the field since its inception in 1969 and continues to thrive as it looks towards 2024. Ranked in the second quartile (Q2) for Biophysics and Physiology, and third quartile (Q3) in Cell Biology, it showcases impactful research that embodies the spirit of scientific inquiry and innovation. Although currently not an Open Access journal, it remains easily accessible to researchers, professionals, and students eager to delve into the dynamic world of membrane studies. As the understanding of membrane dynamics expands, so does its relevance in areas such as drug development and cellular engineering, making the Journal of Membrane Biology an essential resource for those at the forefront of these critical scientific advancements.

PPAR Research

Exploring the Intersection of Biochemistry and Pharmacology
Publisher: HINDAWI LTDISSN: 1687-4757Frequency:

PPAR Research, an esteemed journal published by HINDAWI LTD, specializes in the rapidly evolving fields of drug discovery and pharmacology, contributing significantly to the body of research surrounding peroxisome proliferator-activated receptors (PPARs) and their roles in various biochemical processes. With an open access policy implemented since 2006, the journal ensures that its high-quality content is readily available, promoting widespread dissemination of knowledge. Currently ranked in the Q2 category for both Drug Discovery and Medical Pharmacology, it boasts a respectable position within the scientific community, evidenced by its Scopus rankings. PPAR Research serves as an essential resource for researchers, professionals, and students looking to advance their understanding of PPAR biology and its implications in therapeutic development. The journal's commitment to excellence and accessibility makes it a key player in supporting innovative research and critical discussions in the life sciences.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Advancing insights into nutrition and cardiovascular health.
Publisher: ELSEVIER SCI LTDISSN: 0939-4753Frequency: 12 issues/year

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, published by Elsevier Science Ltd, is a prestigious academic journal dedicated to advancing the knowledge and understanding of the intricate relationships between nutrition, metabolism, and cardiovascular health. With an impressive HIndex and a consistent trajectory of high-impact research, this journal occupies a commendable position in the academic landscape, achieving Q1 rankings in both Cardiology and Cardiovascular Medicine, as well as in Nutrition and Dietetics for the year 2023. The journal’s Scopus rankings further solidify its reputation, occupying top percentiles across various categories, making it an essential resource for researchers, healthcare professionals, and students keen on exploring the latest findings in the field. Although it is not an open access journal, readers can access a wealth of knowledge that spans from 1996 to 2024, with articles that cover diverse topics in endocrinology, diabetes, and metabolism. By disseminating groundbreaking research and reviews, NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES aims to foster innovation and evidence-based practices that contribute to improved health outcomes worldwide.

PROGRESS IN LIPID RESEARCH

Exploring the Complexities of Lipid Metabolism
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0163-7827Frequency: 4 issues/year

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.

Molecular Metabolism

Exploring the Interplay of Metabolism and Health
Publisher: ELSEVIERISSN: 2212-8778Frequency: 12 issues/year

Molecular Metabolism is a premier, open-access journal published by Elsevier, dedicated to advancing the understanding of metabolic processes at the molecular level. With an ISSN of 2212-8778 and a proud presence in Germany, the journal has made significant contributions to the fields of Cell Biology and Molecular Biology, consistently achieving a Q1 ranking in both categories as of 2023. The journal’s scope encompasses cutting-edge research that explores metabolic pathways, their regulation, and implications for human health, underscoring the interplay between metabolism and various biological functions. Researchers and professionals benefit from the journal’s robust visibility, as it ranks #40 among 410 journals in Molecular Biology and #35 among 285 in Cell Biology according to Scopus metrics, placing it in the top 10 percentile in its field. With open access since 2012, Molecular Metabolism ensures that groundbreaking research is available to all, fostering a collaborative and inclusive academic environment. Its commitment to excellence and accessibility makes it an invaluable resource for those invested in metabolic research.